Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myelomaQUACH, H ; RITCHIE, D ; STEWART, A. K ; NEESON, P ; HARRISON, S ; SMYTH, M. J ; PRINCE, H. MLeukemia, 2010-01, Vol.24 (1), p.22-32 [Periódico revisado por pares]Avenel, NJ: Nature Publishing GroupTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
International Myeloma Working Group molecular classification of multiple myeloma: spotlight reviewFONSECA, R ; BERGSAGEL, P. L ; NERI, A ; BARLOGIE, B ; KUEHL, W. M ; LIEBISCH, P ; DAVIES, F ; CHEN-KIANG, S ; DURIE, B. G. M ; CARRASCO, R ; SEZER, Orhan ; REIMAN, Tony ; DRACH, J ; PILARSKI, Linda ; AVET-LOISEAU, H ; SHAUGHNESSY, J ; GUTIERREZ, N ; STEWART, A. K ; MORGAN, G ; VAN NESS, B ; CHESI, M ; MINVIELLE, SLeukemia, 2009-12, Vol.23 (12), p.2210-2221 [Periódico revisado por pares]Avenel, NJ: Nature Publishing GroupTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trialREEDER, C. B ; REECE, D. E ; ZEPEDA, Vhj ; MIKHAEL, J. R ; LEIS, J. F ; BERGSAGEL, P. L ; FONSECA, R ; STEWART, A. K ; KUKRETI, V ; CHEN, C ; TRUDEL, S ; HENTZ, J ; NOBLE, B ; PIROOZ, N. A ; SPONG, J. E ; PIZA, J. GLeukemia, 2009-07, Vol.23 (7), p.1337-1341 [Periódico revisado por pares]Avenel, NJ: Nature Publishing GroupTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Clinically relevant end points and new drug approvals for myelomaANDERSON, K. C ; KYLE, R. A ; RAJKUMAR, S. V ; STEWART, A. K ; WEBER, D ; RICHARDSON, PLeukemia, 2008-02, Vol.22 (2), p.231-239 [Periódico revisado por pares]London: Nature PublishingTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Pomalidomide (CC4047) plus low dose dexamethasone (Pom dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)LACY, M. Q ; HAYMAN, S. R ; ZELDENRUST, S ; FONSECA, R ; BERGSAGEL, P. L ; ROY, V ; MIKHAEL, J. R ; STEWART, A. K ; LAUMANN, K ; ALLRED, J. B ; MANDREKAR, S. J ; RAJKUMAR, S. V ; GERTZ, M. A ; BUADI, F ; SHORT, K. D ; DISPENZIERI, A ; KUMAR, S ; GREIPP, P. R ; LUST, J. A ; RUSSELL, S. J ; DINGLI, DLeukemia, 2010-11, Vol.24 (11), p.1934-1939 [Periódico revisado por pares]Avenel, NJ: Nature Publishing GroupTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Genetic aberrations and survival in plasma cell leukemiaTIEDEMANN, R. E ; GONZALEZ-PAZ, N ; GREIPP, P. R ; DISPENZIERI, A ; LACY, M. Q ; RAJKUMAR, S. V ; BERGSAGEL, P. L ; STEWART, A. K ; FONSECA, R ; KYLE, R. A ; SANTANA-DAVILA, R ; PRICE-TROSKA, T ; VAN WIER, S. A ; CHNG, W. J ; KETTERLING, R. P ; GERTZ, M. A ; HENDERSON, KLeukemia, 2008-05, Vol.22 (5), p.1044-1052 [Periódico revisado por pares]London: Nature PublishingTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276Schmidt, J ; Braggio, E ; Kortuem, K M ; Egan, J B ; Zhu, Y X ; Xin, C S ; Tiedemann, R E ; Palmer, S E ; Garbitt, V M ; McCauley, D ; Kauffman, M ; Shacham, S ; Chesi, M ; Bergsagel, P L ; Stewart, A KLeukemia, 2013-12, Vol.27 (12), p.2357-2365 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapySTEWART, A. K ; BERGSAGEL, P. L ; WITZIG, T. E ; ZELDENRUST, S. R ; DINGLI, D ; REEDER, C. B ; ROY, V ; KYLE, R. A ; RAJKUMAR, S. V ; FONSECA, R ; GREIPP, P. R ; DISPENZIERI, A ; GERTZ, M. A ; HAYMAN, S. R ; KUMAR, S ; LACY, M. Q ; LUST, J. A ; RUSSELL, S. JLeukemia, 2007-03, Vol.21 (3), p.529-534 [Periódico revisado por pares]London: Nature PublishingTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trialAilawadhi, S ; Mikhael, J R ; LaPlant, B R ; Laumann, K M ; Kumar, S ; Roy, V ; Dingli, D ; Bergsagel, P L ; Buadi, F K ; Rajkumar, S V ; Fonseca, R ; Gertz, M A ; Kapoor, P ; Sher, T ; Hayman, S R ; Stewart, A K ; Dispenzieri, A ; Kyle, R A ; Gonsalves, W I ; Reeder, C B ; Lin, Y ; Go, R S ; Leung, N ; Kourelis, T ; Lust, J A ; Russell, S J ; Chanan-Khan, A A ; Lacy, M QLeukemia, 2018-03, Vol.32 (3), p.719-728 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Compromised stem cell mobilization following induction therapy with lenalidomide in myelomaPARIPATI, H ; STEWART, A. K ; BOESIGER, J ; CABOU, S ; DUECK, A ; ZEPEDA, V. J ; PIROOZ, N ; EHLENBECK, C ; REEDER, C ; SLACK, J ; LEIS, J. FLeukemia, 2008-06, Vol.22 (6), p.1282-1284 [Periódico revisado por pares]London: Nature PublishingTexto completo disponível |